Fonte: Growth Hormone & IGF Research. Unidade: FMRP
Assuntos: GRAVIDEZ, HIV, FÁRMACOS, GLICEMIA
ABNT
MARCOLIN, Alessandra C. et al. Evaluation of IGF-2/Apal polymorphism in pregnant women infected with human immunodeficiency virus type 1 taking antiretroviral drugs. Growth Hormone & IGF Research, v. 19, n. 6, p. 513-516, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.ghir.2009.05.003. Acesso em: 16 nov. 2024.APA
Marcolin, A. C., Duarte, G., Quintana, S. M., Araújo, F. M., Beitune, P. E., Gonçalves, C. V., & Ramos, E. S. (2009). Evaluation of IGF-2/Apal polymorphism in pregnant women infected with human immunodeficiency virus type 1 taking antiretroviral drugs. Growth Hormone & IGF Research, 19( 6), 513-516. doi:10.1016/j.ghir.2009.05.003NLM
Marcolin AC, Duarte G, Quintana SM, Araújo FM, Beitune PE, Gonçalves CV, Ramos ES. Evaluation of IGF-2/Apal polymorphism in pregnant women infected with human immunodeficiency virus type 1 taking antiretroviral drugs [Internet]. Growth Hormone & IGF Research. 2009 ; 19( 6): 513-516.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ghir.2009.05.003Vancouver
Marcolin AC, Duarte G, Quintana SM, Araújo FM, Beitune PE, Gonçalves CV, Ramos ES. Evaluation of IGF-2/Apal polymorphism in pregnant women infected with human immunodeficiency virus type 1 taking antiretroviral drugs [Internet]. Growth Hormone & IGF Research. 2009 ; 19( 6): 513-516.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ghir.2009.05.003